SEC Tracker › Core Laboratories › Tables
Fiscal quarters (CLB's year ends in late December) ← Scroll for earlier quarters
In thousands of dollars Q4 FY23 Dec 31, 2023 Q1 FY24 Mar 31, 2024 Q2 FY24 Jun 30, 2024 Q3 FY24 Sep 30, 2024 Q4 FY24 Dec 31, 2024 Q1 FY25 Mar 31, 2025 Q2 FY25 Jun 30, 2025 Q3 FY25 Sep 30, 2025 Q4 FY25 Dec 31, 2025 Q1 FY26 Mar 31, 2026 Q2 FY26 Jun 30, 2026 Q3 FY26 Sep 30, 2026 Revenue from contracts with customers 128,210* 129,637 130,577 134,397 129,237* 123,585 130,159 134,521 138,255* 121,797 124,609 132,077 Cost of goods and services sold year only 104,588 102,930 106,805 106,199* 99,469 103,701 104,901 109,516* 102,073 101,371 105,092 General and administrative year only 11,789 10,259 8,642 9,080* 13,647 10,464 10,688 10,631* 14,718 10,953 11,268 Other operating income (expense) 427* (846) 2,390 4,529 3,880* (2,335) 2,967 5,590 1,392* 645 691 72 Operating income (loss) 14,581* 8,571 16,008 19,803 14,174* 4,417 15,291 20,928 15,832* 1,887 9,151 12,065 Interest expense 3,618* 3,423 3,209 3,108 2,629* 2,602 2,711 2,650 2,609* 2,891 2,846 2,786 Other income (expense) (427)* 846 (2,390) 4,529 3,880* (2,335) 2,967 5,590 1,392* 645 691 72 Income tax expense (benefit) 159* 1,658 3,609 4,691 4,076* 1,746 1,911 3,754 8,094* (251) 507 3,816 Net income (loss) 2,199* 3,220 9,032 11,745 7,403* (154) 10,636 14,239 4,948* (789) 5,956 5,444 Earnings per share, basic USD per share 0.05* 0.07 0.19 0.25 0.16* 0.00 0.23 0.31 0.11* (0.02) 0.13 0.12 Earnings per share, diluted USD per share 0.05* 0.07 0.19 0.25 0.16* 0.00 0.22 0.30 0.11* (0.02) 0.13 0.12 Weighted average shares, basic thousands of shares 46,730* 46,859 46,908 46,922 46,899* 46,773 46,632 46,263 46,050* 46,073 46,030 45,866 Weighted average shares, diluted thousands of shares 47,509* 47,703 47,743 47,820 47,475* 46,773 47,364 47,078 46,895* 46,073 46,878 46,711
Fiscal quarters (CLB's year ends in late December) ← Scroll for earlier quarters
In thousands of dollars Q4 FY23 Dec 31, 2023 Q1 FY24 Mar 31, 2024 Q2 FY24 Jun 30, 2024 Q3 FY24 Sep 30, 2024 Q4 FY24 Dec 31, 2024 Q1 FY25 Mar 31, 2025 Q2 FY25 Jun 30, 2025 Q3 FY25 Sep 30, 2025 Q4 FY25 Dec 31, 2025 Q1 FY26 Mar 31, 2026 Q2 FY26 Jun 30, 2026 Q3 FY26 Sep 30, 2026 Cash and cash equivalents 15,120 14,913 17,695 21,474 19,157 22,107 31,188 25,629 22,702 22,819 22,735 21,376 Accounts receivable 109,352 115,092 115,644 117,591 111,761 117,031 113,909 110,258 113,528 108,277 108,817 115,573 Inventory 71,702 70,711 69,898 65,490 59,402 59,031 59,773 58,241 54,496 57,784 57,961 60,699 Total current assets 223,136 229,047 233,528 235,227 226,606 228,768 237,677 226,914 214,665 214,371 214,360 225,055 Property and equipment, net 99,626 98,521 98,510 97,606 97,063 97,943 97,927 98,031 99,447 99,985 100,390 100,840 Right-of-use asset 53,842 53,636 55,689 56,650 56,488 57,490 55,116 53,980 54,346 54,708 52,870 51,145 Goodwill 99,445 99,445 99,445 99,445 99,445 99,445 99,996 100,012 105,789 105,796 105,796 105,917 Total assets 586,395 587,950 597,799 600,466 590,406 591,519 602,111 591,360 584,010 587,728 586,778 593,518 Accounts payable 33,506 32,486 36,863 33,627 34,549 38,497 41,699 36,945 37,275 39,982 40,163 40,012 Total current liabilities 88,097 85,468 97,598 94,938 97,586 103,727 104,772 95,743 106,015 104,734 101,050 102,732 Long-term debt 163,134 160,370 147,621 139,872 126,111 124,367 124,613 114,103 110,255 114,460 113,861 112,447 Lease liability, non-current 42,076 41,481 42,616 43,727 43,343 43,981 42,420 41,525 42,309 41,285 39,314 37,806 Retained earnings 120,756 123,508 132,070 143,346 150,280 149,657 159,824 173,598 172,662 171,413 176,909 181,894 Total stockholders' equity 224,815 232,155 240,274 250,742 251,991 253,388 261,283 271,347 265,986 268,886 272,669 277,971 Total liabilities and equity 586,395 587,950 597,799 600,466 590,406 591,519 602,111 591,360 584,010 587,728 586,778 593,518 Common shares outstanding (cover page) thousands of shares 46,857 46,900 46,913 46,950 46,827 46,883 46,894 46,563 46,050 46,097 45,885 45,823
Fiscal quarters (CLB's year ends in late December) ← Scroll for earlier quarters
In thousands of dollars Q4 FY23 Dec 31, 2023 Q1 FY24 Mar 31, 2024 Q2 FY24 Jun 30, 2024 Q3 FY24 Sep 30, 2024 Q4 FY24 Dec 31, 2024 Q1 FY25 Mar 31, 2025 Q2 FY25 Jun 30, 2025 Q3 FY25 Sep 30, 2025 Q4 FY25 Dec 31, 2025 Q1 FY26 Mar 31, 2026 Q2 FY26 Jun 30, 2026 Q3 FY26 Sep 30, 2026 Net income (loss) 2,199* 3,220 9,032 11,745 7,403* (154) 10,636 14,239 4,948* (789) 5,956 5,444 Stock-based compensation 1,565* 4,820 (132)* (475)* (458)* 4,159 538* 1,326* 1,114* 5,032 902* 1,284* Depreciation and amortization 3,874* 3,843 3,770 3,676 3,664* 3,717 3,670 3,594 3,668* 3,764 3,825 3,724 Net cash from operating activities 19,429* 5,530 17,146* 13,097* 20,615* 6,660 13,923* 8,502* 7,946* 3,965 7,809* 4,969* Purchases of property and equipment 2,736* 3,052 2,866* 2,729* 4,381* 2,785 3,474* 2,006* 2,944* 3,448 4,687* 3,246* Net cash from investing activities (2,446)* (1,657) (687)* (491)* (3,559)* 772 (1,644)* 2,393* (3,752)* (3,391) (3,931)* (3,191)* Proceeds from issuing common stock year only — — — — — — — — — — — Share repurchases 1,784* 44 162* 196* 4,904* 2,022 2,739* 5,009* 2,656* 3,997 2,691* 1,052* Dividends paid 467* 468 470* 469* 469* 469 469* 465* 466* 460 460* 459* Proceeds from long-term debt 12,000* 14,000 8,000* 16,000* 6,000* 13,000 12,000* 11,000* 12,000* 66,000 15,000* 14,000* Repayments of long-term debt 27,000* 17,000 21,000* 24,000* 20,000* 15,000 12,000* 20,000* 16,000* 62,000 15,625* 15,625* Net cash from financing activities (18,479)* (4,080) (13,677)* (8,827)* (19,373)* (4,482) (3,198)* (16,454)* (7,121)* (457) (3,962)* (3,137)*
Compare with peers The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.
Not investment advice. Not affiliated with the U.S. SEC.